Pharmacokinetics, tissue distribution, excretion and plasma protein binding studies of wogonin in rats

Molecules

Volumn 19, Issue 5, 2014, Pages 5538-5549

  Talbi, Amer ^a   Zhao, Di ^a   Liu, Qingwang ^a   Li, Junxiu ^a   Fan, Ali ^a   Yang, Wei ^a   Han, Xing ^a   Chen, Xijing ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Excretion; Flavonoids; LC MS MS; Scutellaria baicalensis Georgi; Wogonin

Indexed keywords

FLAVANONE DERIVATIVE; PLASMA PROTEIN; PROTEIN BINDING; WOGONIN;

ANIMAL; BIOAVAILABILITY; BLOOD; CHEMISTRY; HUMAN; METABOLISM; NEOPLASMS; PATHOLOGY; RAT; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

ANIMALS; BIOLOGICAL AVAILABILITY; BLOOD PROTEINS; FLAVANONES; HUMANS; NEOPLASMS; PROTEIN BINDING; RATS; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

EID: 84901410500     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules19055538     Document Type: Article

References (34)

1. Tai, M.C.; Tsang, S.Y.; Chang, L.Y.; Xue, H. Therapeutic potential of wogonin: A naturally occurring flavonoid. CNS Drug Rev. 2005, 11, 141-150.
2. Gao, Z.; Huang, K.; Yang, X.; Xu, H. Free radical scavenging and antioxidant activities of flavonoids extracted from the radix of Scutellaria baicalensis Georgi Biochim. Biophys. Acta 1999, 1472, 643-650.
3. You, K.M.; Jong, H.G.; Kim, H.P. Inhibition of cyclooxygenase/ lipoxygenase from human platelets by polyhydroxylated/methoxylated flavonoids isolated from medicinal plants. Arch. Pharm. Res. 1999, 22, 18-24.
4. Park, B.K.; Heo, M.Y.; Park, H.; Kim, H.P. Inhibition of TPA-induced cyclooxygenase-2 expression and skin inflammation in mice by wogonin, a plant flavone from Scutellaria radix. Eur. J. Pharmacol. 2001, 425, 153-157.
5. Chang, Y.L.; Shen, J.J.; Wung, B.S.; Cheng, J.J.; Wang, D.L. Chinese herbal remedy wogonin inhibits monocyte chemotactic protein-1 gene expression in human endothelial cells. Mol. Pharmacol. 2001, 60, 507-513.
6. 2+-dependent endonuclease. Biochem. Pharmacol. 2002, 63, 225-236.
7. Himeji, M.; Ohtsuki, T.; Fukazawa, H.; Tanaka, M.; Yazaki, S.; Ui, S.; Nishio, K.; Yamamoto, H.; Tasaka, K.; Mimura, A. Difference of growth-inhibitory effect of Scutellaria baicalensis-producing flavonoid wogonin among human cancer cells and normal diploid cell. Cancer Lett. 2007, 245, 269-274.
8. 2+-dependent apoptosis. Blood 2008, 111, 2354-2363.
9. Qi, Q.; Peng, J.; Liu, W.; You, Q.; Yang, Y.; Lu, N.; Wang, G.; Guo, Q.L. Toxicological studies of wogonin in experimental animals. Phytother. Res. 2009, 23, 417-422.
10. Peng, J.; Qi, Q.; You, Q.; Hu, R.; Liu, W.; Feng, F.; Wang, G.; Guo, Q.L. Subchronic toxicity and plasma pharmacokinetic studies on wogonin, a natural flavonoid, in Beagle dogs. J. Ethnopharmacol. 2009, 124, 257-262.
11. Zhao, L.; Chen, Z.; Wang, D.D.; Hu, R.; You, Q.D.; Guo, Q.L. Developmental toxicity and genotoxicity studies of wogonin. Regul. Toxicol. Pharmacol. 2011, 60, 212-217.
12. Enomoto, R.; Koshiba, C.; Suzuki, C.; Lee, E. Wogonin potentiates the antitumor action of etoposide and ameliorates its adverse effects. Cancer Chemother. Pharmacol. 2011, 67, 1063-1072.
13. Chen, Y.C.; Shen, S.C.; Lee, W.R.; Lin, H.Y.; Ko, C.H.; Shih C.M.; Yang, L.L. Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch. Toxicol. 2002, 76, 351-359.
14. Lee, D.H.; Lee, T.H.; Jung, C.H.; Kim, Y.H. Wogonin induces apoptosis by activating the AMPK and p53 signaling pathways in human glioblastoma cells. Cell. Signal. 2013, 24, 2216-2225.
15. He, L.; Lu, N.; Dai, Q.S.; Zhao, Y.; Zhao, L.; Wang, H.; Li, Z.Y.; You, Q.D.; Guo, Q.L. Wogonin induced G1 cell cycle arrest by regulating Wnt/β-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells. Toxicology 2013, 312, 36-47.
16. Chow, S.E.; Chang, Y.L.; Chuang, S.F.; Wang, J.S. Wogonin induced apoptosis in human nasopharyngeal carcinoma cells by targeting GSK-3â and ÄNp63. Cancer Chemother. Pharmacol. 2011, 68, 835-845.
17. Song, X.M.; Yao, J.; Wang, F.; Zhou, M.; Zhou, Y.X.; Wang, H.; Wei, L.B.; Zhao, L.; Li, Z.Y.; Lu, N.; et al. Wogonin inhibits tumor angiogenesis via degradation of HIF-1a protein. Toxicol. Appl. Pharmacol. 2013, 271, 144-155.
18. Ho, Y.C.; Lee, S.S.; Yang, F.S.; Yu, C.C.; Chang, Y.C. Inhibitory effects of wogonin on invasion by human oral cancer cells by decreasing the activity of matrix metalloproteinases and urokinase-plasminogen activator. J. Dent. Sci. 2013, Available online: http://dx.doi.org/10.1016/j.jds.2013.02.024 (accessed on 11 April 2013).
19. Chung, H.; Jung, Y.M.; Shin, D.H.; Lee, J.Y.; Oh, M.Y.; Kim, H.J. Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts. Int. J. Cancer 2008, 122, 816-822.
20. Huang, K.F.; Zhang, G.D.; Huang, Y.Q.; Diao, Y. Wogonin induces apoptosis and down-regulates survivin in human breast cancer MCF-7 cells by modulating PI3K-AKT pathway. Int. Immunopharmacol. 2012, 12, 334-341.
21. Wang, W.; Guo, Q.; You, Q.; Zhang, K.; Yang, Y.; Yu, J. Involvement of bax/bcl-2 in wogonin-induced apoptosis of human hepatoma cell line SMMC-7721. Anticancer Drugs 2006, 17, 797-805.
22. Hao, H.P.; Zheng, X.; Wang, G.J. Insights into drug discovery from natural medicines using reverse pharmacokinetics. Trends Pharmacol. Sci. 2014, 35, 168-177.
23. Li, T.; Wang, Y.W.; Wang, Y.L.; Liang, R.X.; Zhang, D.; Zhang, H.H.; Chen, L.; Zhou, Z.M.; Yang, W.P. LC-MS quantification and pharmacokinetics of the multi-constituents of Huangqin Tang in rat plasma after different single oral doses. Yao Xue Xue Bao 2013, 48, 917-924.
24. Zhang, Q.; Ma, Y.M.; Wang, Z.T.; Wang, C.H. Differences in pharmacokinetics and anti-inflammatory effects between decoction and maceration of Sanhuang Xiexin Tang in rats and mice. Planta Med. 2013, 79, 1666-1673.
25. Zhang, Z.Q.; Liu, W.; Zhuang, L.; Wang, J.; Zhang, S. Comparative pharmacokinetics of baicalin, wogonoside, baicalein and wogonin in plasma after oral administration of pure baicalin, radix scutellariae and scutellariae-paeoniae couple extracts in normal and ulcerative colitis rats. Iran. J. Pharm. Res. 2013, 12, 399-409.
26. Di, L.; Umland, J.P.; Trapa, P.E.; Maurer, T.S. Impact of recovery on fraction unbound using equilibrium dialysis. J. Pharm. Sci. 2012, 101, 1327-1335.
27. Aggarwal, B.B.; Sung, B. Pharmacological basis for the role of curcumin in chronic diseases: An age-old spice with modern targets. Trends Pharmacol. Sci. 2009, 30, 85-88.
28. Jones, Q.R.; Warford, J.; Rupasinghe, H.P.; Robertson, G.S. Target-based selection of flavonoids for neurodegenerative disorders. Trends Pharmacol. Sci. 2012, 3, 602-610.
29. Zhang, L.; Lin, G.; Zuo, Z. Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein. Pharm. Res. 2007, 24, 81-89.
30. Chen, X.Y.; Wang, H.Y.; Du, Y.; Zhong, D.F. Quantification of the flavonoid wogonin and its major metabolite wogonin 7β-d-gluduronide in rat plasma by liquid chromatoghraphy-Tandem mass spectrometry. J. Chromatogr. B 2002, 775, 169-178.
31. Li, J.C.; Chen, F.H.; Dong, H.J.; Gao, S. Study on Plasma Concentration and Bioavailability of Wogoninin Beagle's Dogs. Chin. Herb. Med. 2011, 3, 144-149.
32. Li, C.; Zhang, L.; Zhou, L.; Wo, S.K.; Lin, G.; Zuo, Z. Comparison of intestinal absorption and disposition of structurally similar bioactive flavones in Radix Scutellariae. AAPS J. 2012, 14, 23-34.
33. Sterbis, J.R.; Rice, K.R.; Javitt, M.C.; Schenkman, N.S.; Brassell, S.A. Fusion imaging: A novel staging modality in testis cancer. J. Cancer 2010, 1, 223-229.
34. Lin, Z.J.; Desai-Krieger, D.; Shum, L. Simultaneous determination of glipizide and rosiglitazone unbound drug concentrations in plasma by equilibrium dialysis and liquid chromatography-Tandem mass spectrometry. J. Chromatogr. B 2004, 801, 265-272.